Status:
COMPLETED
Αn Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder (ADHD360)
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
7-16 years
Phase:
NA
Brief Summary
ADHD360 will be an innovative integrated platform for early ADHD diagnosis and intervention against its symptoms. In the core of the platform design there will be a serious game along with a mobile ap...
Detailed Description
The ADHD360 project develop an integrated platform having as core elements a serious game along with a mobile application for monitoring of ADHD behaviors in a SMART (Specific, Measurable, Attainable,...
Eligibility Criteria
Inclusion
- (1) Participants should be between 7 and 16 years old
- (2) Diagnosed ADHD by an approved body of Ministry of Health
- (3) Participants willing to follow the study protocol and procedures
- (4) Participants with ADHD symptoms that they are not induced by an organic disease
- (5) Participants' parents voluntarily provided written consent for their children's participation in the study.
Exclusion
- (1) Participants in ADHD group having other disorders apart from ADHD
- (2) Parents who refuse to give written consent for their children's participation in the study.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04362982
Start Date
April 1 2020
End Date
December 30 2021
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Medical Physics, AUTH
Thessaloniki, Greece